Artículos por temáticas

Novel data-driven, equation-free method captures spatio-temporal patterns of neurodegeneration in Parkinson's disease: Application of dynamic mode decomposition to PET

Fu JF, Klyuzhin IS, McKeown MJ, Stoessl AJ, Sossi V.

Neuroimage Clin. 2020;25:102150. doi: 10.1016/j.nicl.2019.102150. Epub 2019 Dec 27.

A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies

Tikhonova MA.

EBioMedicine. 2020 Jan;51:102575. doi: 10.1016/j.ebiom.2019.11.036. Epub 2019 Dec 31.

Resting-state fMRI reveals increased functional connectivity in the cerebellum but decreased functional connectivity of the caudate nucleus in Parkinson's disease

Kaut O, Mielacher C, Hurlemann R, Wüllner U.

Neurol Res. 2020 Jan;42(1):62-67. doi: 10.1080/01616412.2019.1709141. Epub 2020 Jan 3.

Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery

Marotta N, Kim S, Krainc D.

Expert Opin Drug Discov. 2020 Apr;15(4):427-441. doi: 10.1080/17460441.2020.1703671. Epub 2020 Jan 3.

Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease

Li J, Qi X, Sun Y, Zhang Y, Chen J.

Comb Chem High Throughput Screen. 2020;23(1):28-40. doi: 10.2174/1386207323666200102124302.

Empathy and theory of mind in Parkinson's disease: A meta-analysis

Coundouris SP, Adams AG, Henry JD.

Neurosci Biobehav Rev. 2020 Feb;109:92-102. doi: 10.1016/j.neubiorev.2019.12.030. Epub 2019 Dec 31.

Brain mitochondrial impairment in early-onset Parkinson's disease with or without PINK1 mutation

Rango M, Dossi G, Squarcina L, Bonifati C.

Mov Disord. 2020 Mar;35(3):504-507. doi: 10.1002/mds.27946. Epub 2020 Jan 2.

Differences in cognitive profiles between Lewy body and Parkinson's disease dementia

Martini A, Weis L, Schifano R, Pistonesi F, Fiorenzato E, Antonini A, Biundo R.

J Neural Transm (Vienna). 2020 Mar;127(3):323-330. doi: 10.1007/s00702-019-02129-2. Epub 2020 Jan 2.

Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson's disease and healthy controls

Kumari S, Goyal V, Kumaran SS, Dwivedi SN, Srivastava A, Jagannathan NR.

Neurol Sci. 2020 May;41(5):1201-1210. doi: 10.1007/s10072-019-04143-4. Epub 2020 Jan 3.

Validation of the Freezing of Gait Questionnaire in patients with Parkinson's disease treated with deep brain stimulation

Gal O, Polakova K, Brozova H, Bezdicek O, Hoskovcova M, Jech R, Ruzicka E.

Neurol Sci. 2020 May;41(5):1133-1138. doi: 10.1007/s10072-019-04209-3. Epub 2020 Jan 2.

Serum adiponectin levels between patients with Parkinson's disease and those with PSP

Kataoka H, Sugie K.

Neurol Sci. 2020 May;41(5):1125-1131. doi: 10.1007/s10072-019-04216-4. Epub 2020 Jan 2.

The relationship between obstructive sleep apnea and Parkinson's disease: a systematic review and meta-analysis

Sun AP, Liu N, Zhang YS, Zhao HY, Liu XL.

Neurol Sci. 2020 May;41(5):1153-1162. doi: 10.1007/s10072-019-04211-9. Epub 2020 Jan 2.

The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson's disease, revealed by an online questionnaire program

Kawaguchi M, Samura K, Miyagi Y, Okamoto T, Yamasaki R, Sakae N, Yoshida F, Iihara K.

Acta Neurochir (Wien). 2020 Feb;162(2):247-255. doi: 10.1007/s00701-019-04182-y. Epub 2020 Jan 2.

Brain activity during lower limb movements in Parkinson's disease patients with and without freezing of gait

Piramide N, Agosta F, Sarasso E, Canu E, Volontè MA, Filippi M.

J Neurol. 2020 Apr;267(4):1116-1126. doi: 10.1007/s00415-019-09687-1. Epub 2020 Jan 2.

Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease

Petkus AJ, Filoteo JV, Schiehser DM, Gomez ME, Hui JS, Jarrahi B, McEwen S, Jakowec MW, Petzinger GM.

Int J Geriatr Psychiatry. 2020 Apr;35(4):396-404. doi: 10.1002/gps.5255. Epub 2020 Jan 23.